307 related articles for article (PubMed ID: 28562595)
41. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
42. Impaired CD4+ Cytotoxic T Lymphocyte Activity in Polyomavirus BK Infected Kidney Transplant Recipients.
Noshadi N; Yaghoubi R; Afshari A; Forouzanfar M; Soleimanian S
Iran J Allergy Asthma Immunol; 2023 Sep; 22(4):379-389. PubMed ID: 37767680
[TBL] [Abstract][Full Text] [Related]
43. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation.
Fan Y; Bai H; Qian Y; Sun Z; Shi B
Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648
[TBL] [Abstract][Full Text] [Related]
44. [Factors affecting BK polyomavirus infection after kidney transplantation in post-school children and a predictive infection model].
Yan YC; Wang ZG; Qi YB; Feng Y; Feng YH; Jia YL; Cheng FM; Feng GW; Jiang W; Shang WW
Zhonghua Yi Xue Za Zhi; 2023 May; 103(20):1538-1545. PubMed ID: 37246003
[No Abstract] [Full Text] [Related]
45. Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV-related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA.
van Doesum WB; Gard L; Knijff LWD; Niesters HGM; van Son WJ; Stegeman CA; van den Berg A; Groen H; van den Born J; Riezebos-Brilman A; Sanders JS
Transpl Infect Dis; 2022 Dec; 24(6):e13927. PubMed ID: 35916729
[TBL] [Abstract][Full Text] [Related]
46. A prospective study of renal transplant recipients reveals an absence of primary JC polyomavirus infections.
Saundh BK; Baker R; Harris M; Hale A
J Clin Virol; 2016 Apr; 77():101-5. PubMed ID: 26923352
[TBL] [Abstract][Full Text] [Related]
47. BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase.
Justice JL; Needham JM; Thompson SR
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043526
[TBL] [Abstract][Full Text] [Related]
48. Effect of transient BK viremia and viruria on long-term renal allograft survival and function.
Koukoulaki M; Papadaki M; Pistolas D; Balaska A; Hadjicontantinou V; Paniara O; Drakopoulos S
Transplant Proc; 2014 Nov; 46(9):3187-90. PubMed ID: 25420855
[TBL] [Abstract][Full Text] [Related]
49. Meaning of early polyomavirus-BK replication post kidney transplant.
Mitterhofer AP; Pietropaolo V; Barile M; Tinti F; Fioriti D; Mischitelli M; Limonta A; Meçule A; Ferretti G; Poli L; Chiarini F; Berloco PB; Taliani G
Transplant Proc; 2010 May; 42(4):1142-5. PubMed ID: 20534245
[TBL] [Abstract][Full Text] [Related]
50. BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis.
Pendse SS; Vadivel N; Ramos E; Mudge GH; Von Visger T; Fang JC; Chandraker A
J Heart Lung Transplant; 2006 Jul; 25(7):814-9. PubMed ID: 16818124
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.
Hejtmánková A; Roubalová K; Forejtová A; Žáčková Suchanová J; Forstová J; Viklický O; Španielová H
J Med Virol; 2019 May; 91(5):856-864. PubMed ID: 30609063
[TBL] [Abstract][Full Text] [Related]
52. BK Polyomavirus-Specific CD8 T-Cell Expansion In Vitro Using 27mer Peptide Antigens for Developing Adoptive T-Cell Transfer and Vaccination.
Wilhelm M; Kaur A; Wernli M; Hirsch HH
J Infect Dis; 2021 Apr; 223(8):1410-1422. PubMed ID: 32857163
[TBL] [Abstract][Full Text] [Related]
53. A Cell Culture Model of BK Polyomavirus Persistence, Genome Recombination, and Reactivation.
Zhao L; Imperiale MJ
mBio; 2021 Oct; 12(5):e0235621. PubMed ID: 34473564
[TBL] [Abstract][Full Text] [Related]
54. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.
Molnar MZ; Potluri VS; Schaubel DE; Sise ME; Concepcion BP; Forbes RC; Blumberg E; Bloom RD; Shaffer D; Chung RT; Strohbehn IA; Elias N; Azhar A; Shah M; Sawinski D; Binari LA; Talwar M; Balaraman V; Bhalla A; Eason JD; Besharatian B; Trofe-Clark J; Goldberg DS; Reese PP
Am J Transplant; 2022 Feb; 22(2):599-609. PubMed ID: 34613666
[TBL] [Abstract][Full Text] [Related]
55. Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4
Karantanos T; Kim HT; Tijaro-Ovalle NM; Li L; Cutler C; Antin JH; Ballen K; Marty FM; Tan CS; Ritz J; Politikos I; Boussiotis V
Clin Immunol; 2019 Oct; 207():18-23. PubMed ID: 31255803
[TBL] [Abstract][Full Text] [Related]
56. Variations in BK Polyomavirus Immunodominant Large Tumor Antigen-Specific 9mer CD8 T-Cell Epitopes Predict Altered HLA-Presentation and Immune Failure.
Leuzinger K; Kaur A; Wilhelm M; Hirsch HH
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371492
[TBL] [Abstract][Full Text] [Related]
57. Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation.
Siripoon T; Apiwattanakul N; Mongkolrattanakul P; Tongsook C; Unwanatham N; Hongeng S; Kantachuvesiri S; Bruminhent J
Immun Inflamm Dis; 2023 Aug; 11(8):e956. PubMed ID: 37647426
[TBL] [Abstract][Full Text] [Related]
58. Biology of the BKPyV: An Update.
Helle F; Brochot E; Handala L; Martin E; Castelain S; Francois C; Duverlie G
Viruses; 2017 Nov; 9(11):. PubMed ID: 29099746
[TBL] [Abstract][Full Text] [Related]
59. A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.
Girmanova E; Brabcova I; Bandur S; Hribova P; Skibova J; Viklicky O
J Med Virol; 2011 Aug; 83(8):1395-400. PubMed ID: 21618550
[TBL] [Abstract][Full Text] [Related]
60. Time-dependent variations in BK polyomavirus genome from kidney transplant recipients with persistent viremia.
Mineeva-Sangwo O; Van Loon E; Andrei G; Kuypers D; Naesens M; Snoeck R
Sci Rep; 2023 Aug; 13(1):13534. PubMed ID: 37598256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
